Novartis Investigative Site

Chihuahua City, Chihuahua 31203

2 studies enrolling now · 5 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Diffuse Cutaneous Systemic Sclerosis, Gastrointestinal Stromal Tumor (GIST), Renal Cell Carcinoma, Secondary Progressive Multiple Sclerosis (SPMS)

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis — Recruiting now
• A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis — Recruiting now
• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma — Completed
• A Study of Nilotinib Versus Imatinib in GIST Patients — Completed